Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Lifitegrast Ophthalmic Solution in Dry Eye Disease
ChiCTR2500113402Phase 3Completed
- Sponsor
- Eye and ENT Hospital of Fudan University
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in dry eye syndrome (DED) comparing Lifitegrast ophthalmic solution with Vehicle placebo (2 arms). Primary endpoint: Mean change from baseline in inferior corneal fluorescein staining score (ICSS). Started Nov 2025; status: completed.
02
Drugs
lifitegrast
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR2500113402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500113402.